|
| Study | Age | Treatment | RT dose | Disease status | Follow-up (months) |
|
| Gupta et al., 2000 [13] | 64 | RT | 44.2 Gy + R side boost up to 51 Gy | NED | 64 |
| Batstone et al., 2003 [14] | 87 | Palliative RT | (—) | Alive with disease | 11 |
| Ghetu et al., 2011 [15] | 77 | Lumpectomy; whole breast irradiation following breast relapse; rituximab following breast relapse; local RT following lacrimal gland relapse | (—) | NED | 60 |
| Tsang et al., 2001 [16] | 74 | RT for primary breast MALT and resection for Ca ampulla of Vater relapse | (—) | NED | 55 |
| Wright et al., 1996 [17] | 55 | RT | (—) | NED | 168 |
| Zobolas et al., 2002 [18] | 68 | Breast conservation surgery; bilateral axillary lymph node dissection; 6 cycles of CHOP and RT (RT given 6 months after surgery) | (—) | NED | 10 |
| Bailey et al., 1996 [19] | 36 | Excision, chemotherapy, and RT | (—) | NED | 46 |
| Rajendran et al., 2008 [20] | 66 | RT | 4140 cGy in 23 fractions | NED | 72 |
| Matsuda et al., 2014 [21] | 47 | Mastectomy with sentinel node biopsy and radical axillary node dissection | | NED | 6 |
| Arslan et al., 2012 [22] | 69 | CHOP protocol-8 cycles | | NED | 6 |
| Michael et al., 2005 [23] | 59 | 2 cycles of chlorambucil + CHOP | | NED | 24 |
|
Nassif and Ozdemirli, 2013 [24] | 18 | Excision | | Alive with disease | 4 |
| Huber et al., 2002 [25] | 32 | 8 cycles of cyclophosphamide, Oncovin, and prednisolone | | NED | 48 |
| Julen et al., 2009 [26] | 86 | Patey surgery | | NED | 60 |
| Kambouchner et al., 2003 [27] | 37 | No treatment | | NED | 42 |
| Kim et al., 2015 [28] | 55 | Surgery | | NED | 9 |
| Kuper-Hommel et al., 1999 [29] | 65 | 3 cycles of CHOP | | NED | 10 |
| Mattia et al., 1993 [30] | 69 | Excision | | NED | 9 |
| Mattia et al., 1993 [30] | 77 | Excision | | NED | 48 |
| Mattia et al., 1993 [30] | 81 | Excision | | NED | 10 |
| Mattia et al., 1993 [30] | 65 | Excision | | Death from progressive disease | 25 |
| Raderer et al., 2005 [31] | 59 | 4 cycles of oxaliplatin | | NED | 20 |
| Said et al., 2013 [32] | 52 | Cyclophosphamide, steroid, and CHOP | | Death from progressive disease | 12 |
| Taeda et al., 2006 [33] | 84 | Mastectomy with axillary lymph node dissection and 4 cycles of rituximab | | NED | 18 |
| Welsh et al., 2006 [34] | 66 | Lumpectomy and 30.6 Gy in 18 fractions | | NED | 36 |
| Anavekar et al., 2008 [35] | 56 | Surgery, postoperative RT, and tamoxifen | | NED | 24 |
| Kuper-Hommel et al., 2003 [36] | (—) | RT | (—) | Death from unrelated causes | 59 |
| Kuper-Hommel et al., 2003 [36] | (—) | Surgery | | NED | 134 |
| Kuper-Hommel et al., 2003 [36] | (—) | Surgery and anthracycline-containing chemotherapy regimen | | NED | 74 |
| Kuper-Hommel et al., 2003 [36] | (—) | Surgery and chemotherapy | | NED | 66 |
| Kuper-Hommel et al., 2003 [36] | (—) | Surgery | | NED | 16 |
| Kuper-Hommel et al., 2003 [36] | (—) | Surgery and anthracycline-containing chemotherapy regimen | | Death from progressive disease | 107 |
|
